FEED TEST


feed should appear below....

Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
2022-11-09

Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
2022-11-08

Xenon Pharmaceuticals Strengthens Leadership Team with Appointment of Andrea DiFabio as Chief Legal Officer and Corporate Secretary
2022-11-07

Xenon Pharmaceuticals Announces Launch of XEN1101 Phase 3 Program with Initiation of X-TOLE2 Clinical Trial in Patients with Focal Onset Seizures
2022-11-03

SECOND FEED